Clinical Trial Update: Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing edoxaban to warfarin in patients with atrial fibrillation has completed; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Embolism
• Stroke

Drugs mentioned

• Edoxaban (edoxaban)
• Warfarin (warfarin)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Stroke, Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2015-03-25